BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia
Psychosis

Interventions: Device: transcranial direct current stimulation

First Posted Date: 2016-11-29

Last Posted Date: 2020-11-25

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 15

Registration Number: NCT02975973

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)

Phase 1

Completed

Conditions: EBV Related Non-Hodgkin's Lymphoma
EBV-Related PTLD
EBV Related Lymphoma
Hodgkin Lymphoma
NonHodgkin Lymphoma
Lymphoproliferative Disorders
EBV Related Hodgkin's Lymphoma

Interventions: Biological: EBVST Cells
Biological: Nivolumab

First Posted Date: 2016-11-25

Last Posted Date: 2021-07-21

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 8

Registration Number: NCT02973113

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)

Phase 4

Completed

Conditions: Severe Obesity
Hypogonadism

Interventions: Drug: Anastrazole
Behavioral: weight loss

First Posted Date: 2016-11-09

Last Posted Date: 2020-01-30

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 23

Registration Number: NCT02959853

Locations: 🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States

Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma

Phase 1

Completed

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Metformin

First Posted Date: 2016-10-31

Last Posted Date: 2023-06-29

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 26

Registration Number: NCT02949700

Locations: 🇺🇸
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States
🇺🇸
Harris Health System - Smith Clinic, Houston, Texas, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants

Not Applicable

Active, not recruiting

Conditions: Premature Infants

Interventions: Dietary Supplement: Standard Protein Diet
Dietary Supplement: High Protein Diet

First Posted Date: 2016-10-25

Last Posted Date: 2024-02-21

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 118

Registration Number: NCT02943746

Locations: 🇺🇸
Baylor College of Medicine / Texas Children's Hospital, Houston, Texas, United States

Dental Malocclusion and Craniofacial Development in OI

Active, not recruiting

Conditions: Osteogenesis Imperfecta

First Posted Date: 2016-10-17

Last Posted Date: 2024-12-04

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 75

Registration Number: NCT02934451

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
University of California Los Angeles, Los Angeles, California, United States
🇨🇦
Shriners Hospital for Children, Montreal, Quebec, Canada

Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)

Phase 4

Completed

Conditions: Kidney Failure, Chronic

Interventions: Drug: Patiromer 25.2 g

First Posted Date: 2016-10-14

Last Posted Date: 2019-05-09

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 43

Registration Number: NCT02933450

Locations: 🇺🇸
Ben Taub Hospital, Houston, Texas, United States

Low VW Activity in Adolescent HMB

Active, not recruiting

Conditions: Von Willebrand Factor Deficiency

Interventions: Other: Genetic Analysis
Other: Medical Record Data Abstraction
Other: Pictorial Blood Assessment Chart (PBAC) score
Other: Complete Bleeding Symptom ISTH Bleeding Assessment Tool

First Posted Date: 2016-10-14

Last Posted Date: 2022-04-11

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 120

Registration Number: NCT02933411

Locations: 🇺🇸
Children's Hospital of Atlanta, Atlanta, Georgia, United States
🇺🇸
Joseph M Sanzari Children's Hospital, Hackensack, New Jersey, United States
🇺🇸
Michigan State University, East Lansing, Michigan, United States

and more 9 locations

Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)

Phase 1

Active, not recruiting

Conditions: Liver Cancer

Interventions: Genetic: GAP T cells
Drug: Cytoxan
Drug: Fludara

First Posted Date: 2016-10-13

Last Posted Date: 2024-06-21

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 10

Registration Number: NCT02932956

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Cognition in Motion

Not Applicable

Completed

Conditions: Cognitive Performance During Physical Activity

First Posted Date: 2016-10-07

Last Posted Date: 2016-10-07

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 88

Registration Number: NCT02927275

Locations: 🇺🇸
Baylor College of Medicine-Department of Obstetrics & Gynecology, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy